CN102698033A - Traditional Chinese medicine composition for treating vitiligo vulgaris - Google Patents
Traditional Chinese medicine composition for treating vitiligo vulgaris Download PDFInfo
- Publication number
- CN102698033A CN102698033A CN201210116834XA CN201210116834A CN102698033A CN 102698033 A CN102698033 A CN 102698033A CN 201210116834X A CN201210116834X A CN 201210116834XA CN 201210116834 A CN201210116834 A CN 201210116834A CN 102698033 A CN102698033 A CN 102698033A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- medicine composition
- fructus
- flavor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 206010047642 Vitiligo Diseases 0.000 title claims abstract description 23
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 15
- 239000002131 composite material Substances 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- 239000011593 sulfur Substances 0.000 claims description 9
- 241000411851 herbal medicine Species 0.000 claims description 8
- 241001446509 Psoralea Species 0.000 claims description 4
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 210000003734 kidney Anatomy 0.000 abstract description 22
- 210000004185 liver Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 206010040925 Skin striae Diseases 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 3
- 238000010792 warming Methods 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract 2
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 206010025421 Macule Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000021595 spermatogenesis Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 208000028280 polygenic inheritance Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036301 sexual development Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the technical field of medicines, in particular to a traditional Chinese medicine composition for treating vitiligo vulgaris. The traditional Chinese medicine composition comprises an orally-taken medicine composition and an externally-used medicine composition and is characterized in that the orally-taken medicine composition comprises the following Chinese medicinal herbs: by weight, 8-26 parts of rehmannia roots, 10-20 parts of dogwood, 12-30 parts of Chinese yam, 9-14 parts of wart grass, 10-30 parts of poria cocos and 8-16 parts of fructus psoraleae; and the externally-used medicine composition comprises the following Chinese medicinal herbs: by weight, 15-26 parts of fructus psoraleae, 3-12 parts of lithargite and 4-10 parts of sulphur. The traditional Chinese medicine composition treats the vitiligo vulgaris from internal to external, has effects of tonifying the liver and kidney, regulating vital energy and blood and warming and activating meridian and striae, and has good curative effect for treating the vitiligo vulgaris.
Description
Technical field
The present invention relates to medical technical field, be specifically related to a kind of Chinese medicine composition of treating pathogensis of vitiligo vulgaris.
Background technology
Vitiligo (vitiligo) is divided homeliness type and segmental pattern two major types, and pathogensis of vitiligo vulgaris is divided into again: 1, limitation: single-shot or multiple white macula are confined to a certain position; 2, being dispersed in property: be dispersed in, multiple white macula, often be symmetrical distribution; 3, general property: how by being dispersed in sexual development, white macula is many, is fused into irregular sheet mutually, the normal colour of skin of only residual sometimes small pieces island shape; 4, acra property: white macula is just sent out in the acra of human body, and mainly is distributed in these positions.It is a kind of common skin diseases.This disease be the day after tomorrow skin pigment take off that lose to form white macula be characteristic, etiology and pathogenesis is complicated, is result of various factor comprehensive action.In recent years, most scholars think that vitiligo is a kind of autoimmune disease of polygenic inheritance, and humoral immunization and cellular immunization play an important role in vitiligo forms to melanocytic destruction.The influence beauty treatment is prone to the diagnosis refractory and treats.The traditional Chinese medical science is referred to as " leucoderma " or titles such as " vitiligos " again.This disease all has generation all over the world, and Africa and India's sickness rate are higher, and China's sickness rate is about 2%, and southern and northern sickness rate and men and women's sickness rate do not have significant difference.
Chinese medicine thinks that leukodermic main etiology and pathogenesis is stagnation of QI due to depression of the liver, deficiency of the liver and kindey, stagnation of QI-blood.Exopathogen is taken advantage of a weak point in opponent's defence and is attacked, and the visitor goes into the flesh table, and meridians are obstructed, and coagulation of QI-blood, fur space between skin and muscles lose supports and the speckle that turns white.12 meridians, eight extra-channel are invaded by pathogenic factor all can, and all can fall ill in any position of body surface, have the bilateral symmetric property characteristics of incidence, course of disease elder's congestion of holding concurrently more.Lung governing qi is at body and skin, its Hua Zaimao.Have Xuan Fawei gas, semen deposition is in physiological functions such as furs.The Chinese traditional treatment pathogensis of vitiligo vulgaris adopts tonifying liver lung kidney more, regulate the flow of vital energy and the method for treatment of blood, invigorating striae of the skin.
Summary of the invention
It is a kind of effective to the segmental pattern therapy of vitiligo that technical problem to be solved by this invention is to provide, and the mode of ruling together is treated the Chinese medicine composition of pathogensis of vitiligo vulgaris inside and outside the employing.
Technical problem to be solved by this invention adopts following technical scheme to realize:
A kind of Chinese medicine composition of treating pathogensis of vitiligo vulgaris; Form by oral medicine compositions and externally-applied medicine composite; It is characterized in that: described oral medicine compositions is made up of Radix Rehmanniae, Fructus Corni, Rhizoma Dioscoreae, Herba Euphorbiae Helioscopiae, Poria, Fructus Psoraleae 6 flavor Chinese herbal medicine, and said externally-applied medicine composite is made up of Fructus Psoraleae, Lithargyrum, sulfur 3 flavor Chinese herbal medicine;
The ratio of weight and number of Chinese herbal medicine of wherein respectively distinguishing the flavor of in the oral medicine compositions is Radix Rehmanniae 8-26 part, Fructus Corni 10-20 part, Rhizoma Dioscoreae 12-30 part, Herba Euphorbiae Helioscopiae 9-14 part, Poria 10-30 part, Fructus Psoraleae 8-16 part;
The ratio of weight and number of Chinese herbal medicine of wherein respectively distinguishing the flavor of in the externally-applied medicine composite is Fructus Psoraleae 15-26 part, Lithargyrum 3-12 part, sulfur 4-10 part.
The optimum weight portion rate of medicine of respectively distinguishing the flavor of in the above-mentioned oral medicine compositions is: 10 parts of Radix Rehmanniae, 12 parts of Fructus Corni, 16 parts of Rhizoma Dioscoreaes, 10 parts of Herba Euphorbiae Helioscopiae, 15 parts in Poria, 10 parts of Fructus Psoraleaes.
The optimum weight portion rate of medicine of respectively distinguishing the flavor of in the above-mentioned externally-applied medicine composite is: 20 parts of Fructus Psoraleaes, 10 parts of Lithargyrums, 8 parts in sulfur.
Preparation of the present invention and method for using:
With the medicine proportional mixing of respectively distinguishing the flavor of in the above-mentioned oral medicine compositions, process medicament by the method for the fried Chinese medicine of routine, every dose of 600ml, the morning, noon and afternoon one after each meal, 90 days is a course of treatment.
It is subsequent use that the medicine of respectively distinguishing the flavor of in the above-mentioned externally-applied medicine composite is ground to form the superfine powder mixing in proportion; With the fresh Fructus Solani melongenae base of a fruit, promptly the Fructus Solani melongenae band base of a fruit one end cuts off apart from the base of a fruit 3～4cm place, dips in medicated powder and embrocates the affected part, and friction gently treats that white macula is slight rubescent for beneficial, morning, noon and afternoon every day 3 times, 90 days per courses of treatment.
Inside and outside rule together, liver and kidney tonifying is arranged, regulates the flow of vital energy and the effect of blood, invigorating striae of the skin.The treatment pathogensis of vitiligo vulgaris has curative effect preferably.
In the medical material provided by the present invention:
Radix Rehmanniae: sweet, bitter, cold.GUIXIN, liver, lung meridian.Clearing away heat and cooling blood, the yin nourishing spermatogenesis.Join the army branch, blood system are the key medicine of clearing away heat and cooling blood yin nourishing spermatogenesis.Control that heat in blood is told nosebleed, the metrorrhagia of having blood in stool, interior-heat quench one's thirst.
Fructus Corni: sour, puckery, tepor.Return liver, kidney channel.Liver and kidney tonifying is restrained astringent or styptic treatment for spontaneous sweating.Be used for caused by liver and kidney deficiency, have a dizzy spell, soreness of the waist and knees, diseases such as sexual impotence; The kidney invigorating helps essence, warming the kidney to activate YANG, and YANG invigorating is the key medicine of liver and kidney tonifying; Controlling suffers from a deficiency of the kidney does not cause seminal emission, bed wetter admittedly; Also can be used for the women because of deficiency of both the liver and kidney, the metrostaxis due to the debility of CHONG and REN meridians and the card of menorrhagia; Control big collapse person.
Rhizoma Dioscoreae: sweet, flat.Return spleen, lung, kidney channel.Supplementing QI and nourishing YIN, spleen reinforcing lung kidney, treating spontaneous emission and leukorrhagia.Be used for insufficiency of the spleen lack of appetite, the tired loose stool of body; The both gas of spleen reinforcing lung, the moon of lung benefiting kidney again, and can astringent or styptic treatment for spontaneous sweating kidney essense; The effect that has the QI invigorating YIN nourishing and the production of body fluid promoting to quench the thirst.
Herba Euphorbiae Helioscopiae: hot, bitter, be slightly cold; Poisonous.Return large intestine, small intestinal, lung meridian.Inducing diuresis to remove edema, the detumescence of reducing phlegm, eliminating stagnation.Be used for extensive abdominal edema, the facial edema of extremity is with stronger inducing diuresis to remove edema effect; The merit that expectorant cough suppressant and anti-asthmatic is arranged; Control tinea skin ulcer pruritus.
Poria: sweet, light, flat.GUIXIN, spleen, kidney channel.Promoting diuresis to eliminate damp pathogen, spleen-benefiting mind-tranquilizing.Control the various edema of cold and heat and asthenia and sthenia; Control weakness of the spleen and stomach, lack of appetite is indigestion and loss of appetite, fatigue and weakness etc.; Deficiency of both the heart and spleen, the malaise of insufficiency of vital energy and blood.
Fructus Psoraleae: hot, bitter, temperature.Return kidney, spleen channel.Warming the kidney to activate YANG, improving inspiration by invigorating kidney-QI, antidiarrheal.Be used for impotence and seminal emission, enuresis frequent micturition, chills and pain of the waist and kness is suffered from a deficiency of the kidney and is done to breathe heavily, and has loose bowels just before dawn; The external curing vitiligo, alopecia areata.
Sulfur: acid, temperature.Poisonous.Return kidney, large intestine channel.External detoxifcation parasite killing is treated skin ulcer, the fiery supporing yang relieving constipation of benefit for oral administration.
Lithargyrum: salty, hot, flat, poisonous.Return liver, spleen channel.Function cures mainly: dampness, kill convergence; Anticorrosion, detoxifcation.Main skin infection festers and does not restrain for a long time, aphtha, and scabies, bromhidrosis, tinea versicolor, (black doing) is dim, wine Zha nose, burn and scald, eczema.
The invention has the beneficial effects as follows: medicine compatibility of the present invention is reasonable, and is good to the pathogensis of vitiligo vulgaris therapeutic effect, the mode of ruling together inside and outside the employing; Square benefiting qi and nourishing blood for oral administration, promoting blood circulation to remove obstruction in the collateral, tonifying liver lung kidney, harmonizing yingfen and weifen, invigorating striae of the skin increase the reparation of melanocyte generation and impaired melanocyte function, promote white macula to recover; The detoxifcation of dispeling the wind of external side, is dispersed a mao key at promoting blood circulation to remove obstruction in the collateral, the effect that the QI-blood circulation that increases skin and a surname's issue are loose; Stimulate melanocyte to generate and melanic secretion; Inside and outside rule together, liver and kidney tonifying, regulate the flow of vital energy and blood, invigorating striae of the skin, the treatment pathogensis of vitiligo vulgaris has curative effect preferably.
The specific embodiment
For technological means, creation characteristic that the present invention is realized, reach purpose and effect and be easy to understand and understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment one
The oral medicine compositions takes by weighing Radix Rehmanniae 10g, Fructus Corni 12g, Rhizoma Dioscoreae 16g, Herba Euphorbiae Helioscopiae 10g, Poria 15g, Fructus Psoraleae 10g.More than all medicines add water 1000ml after mixing, soaks after 1 hour, used slow fire boiling instead 30 minutes, extracting juice 300ml after being fried boiling with high heat earlier; After the placement, continue and add water, 1000ml, decoction uses the same method; Extracting juice 300ml, two juice convert evenly, the morning, noon and afternoon one after each meal, and 90 days is a course of treatment.
Externally-applied medicine composite takes by weighing Fructus Psoraleae 20g, Lithargyrum 10g, sulfur 8g, and it is subsequent use that each flavor medicine is ground to form superfine powder.During use, with the fresh Fructus Solani melongenae base of a fruit, the promptly fresh Fructus Solani melongenae band base of a fruit one end cuts off apart from the base of a fruit 3～4cm place, dips in medicated powder and embrocates the affected part, and friction gently treats that friction place is slight rubescent for beneficial, every day 3-4 time, 90 days per courses of treatment.
Embodiment two
The oral medicine compositions takes by weighing Radix Rehmanniae 15g, Fructus Corni 18g, Rhizoma Dioscoreae 26g, Herba Euphorbiae Helioscopiae 10g, Poria 23g, Fructus Psoraleae 16g.More than all medicines add water 1000ml after mixing, soaks after 1 hour, used slow fire boiling instead 30 minutes after being fried boiling with high heat earlier, after the extracting juice 300ml placement; Continuous add water 1000ml after, the decoction that uses the same method, extracting juice 300ml; Two juice are converted evenly, divide one after each meal sooner or later, and 90 days is a course of treatment.
Externally-applied medicine composite takes by weighing Fructus Psoraleae 20g, Lithargyrum 10g, sulfur 8g, and it is subsequent use to grind to form the superfine powder mixing.During use, with the fresh Fructus Solani melongenae base of a fruit, promptly the Fructus Solani melongenae band base of a fruit one end cuts off apart from the base of a fruit 3～4cm place, dips in medicated powder and embrocates the affected part, and friction gently treats that white macula is slight rubescent for beneficial, morning, noon and afternoon every day 3 times, 90 days per courses of treatment.
More than show and described ultimate principle of the present invention and principal character and advantage of the present invention.The technical staff of the industry should understand; The present invention is not restricted to the described embodiments; That describes in the foregoing description and the description just explains principle of the present invention; Under the prerequisite that does not break away from spirit and scope of the invention, the present invention also has various changes and modifications, and these variations and improvement all fall in the scope of the invention that requires protection.The present invention requires protection domain to be defined by appending claims and equivalent thereof.
Claims (3)
1. Chinese medicine composition of treating pathogensis of vitiligo vulgaris; Form by oral medicine compositions and externally-applied medicine composite; It is characterized in that: described oral medicine compositions is made up of Radix Rehmanniae, Fructus Corni, Rhizoma Dioscoreae, Herba Euphorbiae Helioscopiae, Poria, Fructus Psoraleae 6 flavor Chinese herbal medicine, and said externally-applied medicine composite is made up of Fructus Psoraleae, Lithargyrum, sulfur 3 flavor Chinese herbal medicine;
The ratio of weight and number of Chinese herbal medicine of wherein respectively distinguishing the flavor of in the oral medicine compositions is Radix Rehmanniae 8-26 part, Fructus Corni 10-20 part, Rhizoma Dioscoreae 12-30 part, Herba Euphorbiae Helioscopiae 9-14 part, Poria 10-30 part, Fructus Psoraleae 8-16 part;
The ratio of weight and number of Chinese herbal medicine of wherein respectively distinguishing the flavor of in the externally-applied medicine composite is Fructus Psoraleae 15-26 part, Lithargyrum 3-12 part, sulfur 4-10 part.
2. a kind of Chinese medicine composition of treating pathogensis of vitiligo vulgaris according to claim 1 is characterized in that: the optimum weight portion rate of the medicine of respectively distinguishing the flavor of in the described oral medicine compositions is: 10 parts of Radix Rehmanniae, 12 parts of Fructus Corni, 16 parts of Rhizoma Dioscoreaes, 10 parts of Herba Euphorbiae Helioscopiae, 15 parts in Poria, 10 parts of Fructus Psoraleaes.
3. a kind of Chinese medicine composition of treating pathogensis of vitiligo vulgaris according to claim 1 is characterized in that: the optimum weight portion rate of the medicine of respectively distinguishing the flavor of in the described externally-applied medicine composite is: 20 parts of Fructus Psoraleaes, 10 parts of Lithargyrums, 8 parts in sulfur.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210116834 CN102698033B (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating vitiligo vulgaris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210116834 CN102698033B (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating vitiligo vulgaris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102698033A true CN102698033A (en) | 2012-10-03 |
| CN102698033B CN102698033B (en) | 2013-09-25 |
Family
ID=46891280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210116834 Expired - Fee Related CN102698033B (en) | 2012-04-19 | 2012-04-19 | Traditional Chinese medicine composition for treating vitiligo vulgaris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102698033B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013725A (en) * | 2014-06-24 | 2014-09-03 | 任兴文 | Traditional Chinese medicinal prescription for treating leukoderma |
| CN105168325A (en) * | 2015-09-30 | 2015-12-23 | 河南行知专利服务有限公司 | Preparation method and application of non-decocted fructus psoraleae preparation |
| CN106466413A (en) * | 2015-08-15 | 2017-03-01 | 临安市野生中草药配方研究所 | A kind of Chinese herbal medicine formula treating vitiligo oral administration and externally |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171962A (en) * | 1997-06-26 | 1998-02-04 | 王敬泽 | Suyuwan pill for curing leucoderma |
| CN1183301A (en) * | 1997-11-19 | 1998-06-03 | 江百祯 | Capsule for treatment of leukoderma |
| CN1335164A (en) * | 2001-07-26 | 2002-02-13 | 刘双义 | Leukoderma treating medicine and its prepn |
| CN101618149A (en) * | 2008-06-30 | 2010-01-06 | 刘芳 | Traditional Chinese medicine for treating leucoderma |
-
2012
- 2012-04-19 CN CN 201210116834 patent/CN102698033B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1171962A (en) * | 1997-06-26 | 1998-02-04 | 王敬泽 | Suyuwan pill for curing leucoderma |
| CN1183301A (en) * | 1997-11-19 | 1998-06-03 | 江百祯 | Capsule for treatment of leukoderma |
| CN1335164A (en) * | 2001-07-26 | 2002-02-13 | 刘双义 | Leukoderma treating medicine and its prepn |
| CN101618149A (en) * | 2008-06-30 | 2010-01-06 | 刘芳 | Traditional Chinese medicine for treating leucoderma |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104013725A (en) * | 2014-06-24 | 2014-09-03 | 任兴文 | Traditional Chinese medicinal prescription for treating leukoderma |
| CN104013725B (en) * | 2014-06-24 | 2015-12-02 | 任兴文 | Be used for the treatment of leukodermic Chinese medicinal formulae |
| CN106466413A (en) * | 2015-08-15 | 2017-03-01 | 临安市野生中草药配方研究所 | A kind of Chinese herbal medicine formula treating vitiligo oral administration and externally |
| CN105168325A (en) * | 2015-09-30 | 2015-12-23 | 河南行知专利服务有限公司 | Preparation method and application of non-decocted fructus psoraleae preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102698033B (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102119989B (en) | Traditional Chinese medicine capsule for treating lumbar intervertebral disc protrusion, hyperosteogeny, periarthritis humeroscapularis, arthritis and cervical spondylosis | |
| CN101766773A (en) | Traditional Chinese medicine formula for treating heel pain | |
| CN100548350C (en) | A kind of Chinese medicine for the treatment of thromboangiitis obliterans | |
| CN103550685B (en) | A kind of Chinese medicine composition for the treatment of lumbago and skelalgia | |
| CN102698033B (en) | Traditional Chinese medicine composition for treating vitiligo vulgaris | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN102240337A (en) | Formulas of internal medicine and external medicine for treating leucoderma | |
| CN102139032B (en) | Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease | |
| CN109821002A (en) | A kind of Chinese herbs paste suitable for cancer pain | |
| CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
| CN103446347B (en) | Medical aquilaria sinensis moxibustion stick for treating chronic stomach illness | |
| CN106177098A (en) | A kind of pill medicine treating soreness of waist and knee joint and preparation method thereof | |
| CN106038726A (en) | Blood-activating pain-stopping powder | |
| CN104352737A (en) | Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain | |
| CN104398712A (en) | Chinese medicinal preparation for treating facial spasm and preparation method | |
| CN104189672A (en) | Ointment for treating fasciitis | |
| CN103463463A (en) | Traditional Chinese medicine preparation for replenishing and activating blood and dispelling wind and removing dampness | |
| CN102614484B (en) | Bathing traditional Chinese medicine for adjuvant therapy of cerebral thrombosis and hypertension and method for preparing same | |
| CN107137613A (en) | A kind of external application Chinese medicine for treating cervical spondylopathy | |
| CN107233560A (en) | It is a kind of effectively to treat decoction medicine of liver and gallbladder damp-heat and preparation method thereof | |
| CN106110215A (en) | A kind of medicine treating varicose veins of the lower extremity | |
| CN106074992A (en) | A kind of medical herbs for oral administration treating chest traumatic injury wound and using method thereof | |
| CN105168973A (en) | Traditional Chinese medicine for treating cervical spondylosis and lumbar spondylosis | |
| CN102688318B (en) | Traditional Chinese medicine composition for treating segmental vitiligo | |
| CN105998592A (en) | Traditional Chinese medicament for treating cervical spondylosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130925 Termination date: 20210419 |